ENTRY       D06717            Crude     Drug
NAME        Safflower (JP18);
            Safflower (TN)
COMPONENT   Carthamin [CPD:C16941], Safflor yellow, Carthamidin [CPD:C16940], Neocarthamin [CPD:C17675], Lignan, Flavonoid [CPD:C01579], Sterol [CPD:C00370]
SOURCE      Carthamus tinctorius [TAX:4222]
REMARK      Therapeutic category: 5100
            Product: D06717<JP>
EFFICACY    Emmenagogue
COMMENT     Asteraceae (daisy family) Safflower petal
            Major component: Carthamin [CPD:C16941]
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             5  Crude drugs and Chinese medicine formulations
              51  Crude drugs
               510  Crude drugs
                5100  Crude drugs
                 D06717  Safflower (JP18)
            Classification of Japanese OTC drugs [BR:br08313]
             Drugs for women
              49 Drugs for women's health
               D06717  Safflower (JP18)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Crude drugs
               Safflower
                D06717  Safflower (JP18)
            Traditional Chinese Medicine in Japan [BR:br08304]
             Crude drugs
              Drugs for blood
               Drugs for removing blood stasis
                D06717  Safflower; Safflower
              Drugs for external use
               Drugs for external use
                D06717  Safflower; Safflower
            Crude drugs [BR:br08305]
             Dicot plants: asterids
              Asteraceae (daisy family)
               D06717  Safflower
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Crude drugs
              D06717  Safflower
DBLINKS     PubChem: 47208368
///
